News18 » Videos » News18 Shorts

Serum Institute Of India To Begin AstraZeneca-Oxford’s COVID-19 Vaccine Trial In India

Jul 21, 2020 03:33 PM IST India India
Share

SII’s CEO, Adar Poonawalla, said that just when the Indian regulator grants permission they will begin with vaccine trials in India. He also added that the company will soon start manufacturing the vaccine in large volumes.

Loading